1. Home
  2. RGEN vs DBX Comparison

RGEN vs DBX Comparison

Compare RGEN & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • DBX
  • Stock Information
  • Founded
  • RGEN 1981
  • DBX 2007
  • Country
  • RGEN United States
  • DBX United States
  • Employees
  • RGEN N/A
  • DBX N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • DBX Computer Software: Prepackaged Software
  • Sector
  • RGEN Health Care
  • DBX Technology
  • Exchange
  • RGEN Nasdaq
  • DBX Nasdaq
  • Market Cap
  • RGEN 7.6B
  • DBX 8.9B
  • IPO Year
  • RGEN N/A
  • DBX 2018
  • Fundamental
  • Price
  • RGEN $160.51
  • DBX $30.56
  • Analyst Decision
  • RGEN Buy
  • DBX Hold
  • Analyst Count
  • RGEN 12
  • DBX 8
  • Target Price
  • RGEN $187.44
  • DBX $28.86
  • AVG Volume (30 Days)
  • RGEN 521.6K
  • DBX 2.9M
  • Earning Date
  • RGEN 02-19-2025
  • DBX 02-13-2025
  • Dividend Yield
  • RGEN N/A
  • DBX N/A
  • EPS Growth
  • RGEN N/A
  • DBX 9.62
  • EPS
  • RGEN N/A
  • DBX 1.76
  • Revenue
  • RGEN $633,513,000.00
  • DBX $2,539,600,000.00
  • Revenue This Year
  • RGEN $2.28
  • DBX $2.69
  • Revenue Next Year
  • RGEN $9.88
  • DBX $0.58
  • P/E Ratio
  • RGEN N/A
  • DBX $17.36
  • Revenue Growth
  • RGEN N/A
  • DBX 3.01
  • 52 Week Low
  • RGEN $113.50
  • DBX $20.68
  • 52 Week High
  • RGEN $211.13
  • DBX $33.43
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 62.61
  • DBX 59.62
  • Support Level
  • RGEN $150.23
  • DBX $29.01
  • Resistance Level
  • RGEN $160.64
  • DBX $30.32
  • Average True Range (ATR)
  • RGEN 6.76
  • DBX 0.51
  • MACD
  • RGEN 1.14
  • DBX -0.04
  • Stochastic Oscillator
  • RGEN 80.27
  • DBX 83.50

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About DBX Dropbox Inc.

Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.

Share on Social Networks: